Market News / Story
Quantum BioPharma Ltd. (QNTM) Engages Thermo Fisher’s CRO to Implement Phase 2 Lucid-MS Trial
·
Quantum BioPharma signed a Study Start-Up Agreement with Thermo Fisher’s PPD Clinical Research Business to implement its FDA-cleared Phase 2 trial of Lucid-MS in progressive multiple sclerosis. Material Details #DetailAI Analyst View1SUA signed with Thermo Fisher’s PPDDe-risks trial execution and timelines by securing a top-tier CRO.2Phase 2 Lucid-MS implementationMoves program from planning to operational start-up—key value inflection.3FDA cleared Phase 2 to…